China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.46M | -1.14M | -1.22M | -651.50K | -528.40K |
| Total Depreciation and Amortization | 1.14M | 980.60K | 573.00K | 356.00K | 320.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.10K | -1.40K | -13.65M | 109.20K | 211.60K |
| Change in Net Operating Assets | 274.40K | 108.70K | 14.45M | -50.80K | 270.20K |
| Cash from Operations | -32.80K | -55.30K | 152.00K | -237.00K | 274.30K |
| Capital Expenditure | -- | -- | -500.00 | -600.00 | 100.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -5.30K | -40.00K | -- |
| Cash from Investing | -- | -- | -5.80K | -40.60K | 100.00 |
| Total Debt Issued | 163.50K | -- | 707.60K | -740.20K | 993.70K |
| Total Debt Repaid | -43.30K | -79.30K | -780.20K | 618.00K | -1.02M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 120.10K | -79.30K | -72.60K | -122.20K | -22.40K |
| Foreign Exchange rate Adjustments | 49.10K | -42.00K | 3.90K | 42.40K | -39.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.40K | -176.60K | 77.50K | -357.40K | 212.30K |